<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25555913</PMID><DateCompleted><Year>2015</Year><Month>05</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>290</Volume><Issue>9</Issue><PubDate><Year>2015</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>&#x3b2;2-Glycoprotein I-specific T cells are associated with epitope spread to lupus-related autoantibodies.</ArticleTitle><Pagination><StartPage>5543</StartPage><EndPage>5555</EndPage><MedlinePgn>5543-55</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.M114.619817</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) is a prototypic model for B cell epitope spread in autoimmunity. Autoantibodies to numerous and molecularly distinct self-antigens emerge in a sequential manner over several years, leading to disease manifestations. Among the earliest autoantibodies to appear are those targeting the apoptotic cell-binding protein &#x3b2;2-glycoprotein I (&#x3b2;2GPI). Notably, mice immunized with &#x3b2;2GPI and LPS display a remarkably similar pattern of autoantibody emergence to that seen in human SLE. Here, we used this model to investigate whether epitope spread to SLE-related autoantibodies is associated with a unique or limited &#x3b2;2GPI-specific T cell response. We ask whether MHC class II haplotype and its associated T cell epitope restriction impact epitope spread to SLE-related autoantibodies. We found that &#x3b2;2GPI/LPS-immunized mice produced similar SLE-related autoantibody profiles regardless of their &#x3b2;2GPI T cell epitope specificity or MHC class II haplotype. Although &#x3b2;2GPI T cell epitope specificity was clearly determined by MHC class II haplotype, a number of different &#x3b2;2GPI T cell epitopes were associated with epitope spread to SLE-related autoantibodies. Notably, one &#x3b2;2GPI T cell epitope (peptide 23, NTGFYLNGADSAKCT) was also recognized by T cells from an HLA-DRB1*0403(+) autoimmune patient. These data suggest that the generation of a &#x3b2;2GPI-reactive T cell response is associated with epitope spread to SLE-related autoantibodies, independent of epitope specificity or MHC class II restriction. On the basis of these findings, we propose that factors enabling a &#x3b2;2GPI-reactive T cell response may predispose individuals to the development of SLE-related autoantibodies independent of their MHC class II haplotype.</AbstractText><CopyrightInformation>&#xa9; 2015 by The American Society for Biochemistry and Molecular Biology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salem</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>From the Division of Rheumatology, Department of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec H3G 1A4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subang</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Division of Rheumatology, Department of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec H3G 1A4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okazaki</LastName><ForeName>Yuka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>the Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laplante</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>From the Division of Rheumatology, Department of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec H3G 1A4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levine</LastName><ForeName>Jerrold S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>the Section of Nephrology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, and the Section of Nephrology, Department of Medicine, Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois 60612.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuwana</LastName><ForeName>Masataka</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>the Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rauch</LastName><ForeName>Joyce</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>From the Division of Rheumatology, Department of Medicine, Research Institute of the McGill University Health Centre, Montreal, Quebec H3G 1A4, Canada, joyce.rauch@mcgill.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MOP-42391</GrantID><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant><Grant><GrantID>MOP-67101</GrantID><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant><Grant><GrantID>MOP-97916</GrantID><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant><Grant><GrantID>MUS-67101</GrantID><Agency>Canadian Institutes of Health Research</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018984">Epitopes, T-Lymphocyte</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059811">HLA-DRB1 Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C526364">HLA-DRB1*04:03 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000949">Histocompatibility Antigens Class II</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053482">beta 2-Glycoprotein I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018984" MajorTopicYN="N">Epitopes, T-Lymphocyte</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059811" MajorTopicYN="N">HLA-DRB1 Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000949" MajorTopicYN="N">Histocompatibility Antigens Class II</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006825" MajorTopicYN="N">Hybridomas</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008809" MajorTopicYN="N">Mice, Inbred C3H</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053482" MajorTopicYN="N">beta 2-Glycoprotein I</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Animal Model</Keyword><Keyword MajorTopicYN="N">Autoantibodies</Keyword><Keyword MajorTopicYN="N">Autoimmune Disease</Keyword><Keyword MajorTopicYN="N">Epitope Mapping</Keyword><Keyword MajorTopicYN="N">Epitope Spread</Keyword><Keyword MajorTopicYN="N">Major Histocompatibility Complex (MHC)</Keyword><Keyword MajorTopicYN="N">Systemic Lupus Erythematosus</Keyword><Keyword MajorTopicYN="N">T Cell</Keyword><Keyword MajorTopicYN="N">&#x3b2;2-Glycoprotein I</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25555913</ArticleId><ArticleId IdType="pmc">PMC4342469</ArticleId><ArticleId IdType="doi">10.1074/jbc.M114.619817</ArticleId><ArticleId IdType="pii">S0021-9258(19)46830-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arbuckle M. R., McClain M. T., Rubertone M. V., Scofield R. H., Dennis G. J., James J. A., Harley J. B. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349, 1526&#x2013;1533</Citation><ArticleIdList><ArticleId IdType="pubmed">14561795</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos G. C. (2011) Systemic lupus erythematosus. N. Engl. J. Med. 365, 2110&#x2013;2121</Citation><ArticleIdList><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>McClain M. T., Arbuckle M. R., Heinlen L. D., Dennis G. J., Roebuck J., Rubertone M. V., Harley J. B., James J. A. (2004) The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum. 50, 1226&#x2013;1232</Citation><ArticleIdList><ArticleId IdType="pubmed">15077305</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine J. S., Subang R., Nasr S. H., Fournier S., Lajoie G., Wither J., Rauch J. (2006) Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus. J. Immunol. 177, 6504&#x2013;6516</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3439500</ArticleId><ArticleId IdType="pubmed">17056583</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolomeo T., Rico De Souza A., Roter E., Dieud&#xe9; M., Amireault P., Subang R., Levine J. S., Rauch J. (2009) T cells demonstrate a Th1-biased response to native &#x3b2;2-glycoprotein I in a murine model of anti-phospholipid antibody induction. Autoimmunity 42, 292&#x2013;295</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3429410</ArticleId><ArticleId IdType="pubmed">19811280</ArticleId></ArticleIdList></Reference><Reference><Citation>Price B. E., Rauch J., Shia M. A., Walsh M. T., Lieberthal W., Gilligan H. M., O'Laughlin T., Koh J. S., Levine J. S. (1996) Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta2-glycoprotein I-dependent manner. J. Immunol. 157, 2201&#x2013;2208</Citation><ArticleIdList><ArticleId IdType="pubmed">8757347</ArticleId></ArticleIdList></Reference><Reference><Citation>Casciola-Rosen L. A., Anhalt G., Rosen A. (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317&#x2013;1330</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2191465</ArticleId><ArticleId IdType="pubmed">7511686</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian Y., Wang H., Clarke S. H. (2004) Impaired clearance of apoptotic cells induces the activation of autoreactive anti-Sm marginal zone and B-1 B cells. J. Immunol. 172, 625&#x2013;635</Citation><ArticleIdList><ArticleId IdType="pubmed">14688375</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine J., Subang R., Setty S., Cabrera J., Laplante P., Fritzler M., Rauch J. (2014) Phospholipid-binding proteins differ in their capacity to induce autoantibodies and murine systemic lupus erythematosus. Lupus 23, 752&#x2013;768</Citation><ArticleIdList><ArticleId IdType="pubmed">24695867</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Yoshida K., Kaburaki J., Inoko H., Ikeda Y., Kawakami Y., Kuwana M. (2001) Autoreactive CD4+ T-cell clones to &#x3b2;2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site. Blood 98, 1889&#x2013;1896</Citation><ArticleIdList><ArticleId IdType="pubmed">11535526</ArticleId></ArticleIdList></Reference><Reference><Citation>Hattori N., Kuwana M., Kaburaki J., Mimori T., Ikeda Y., Kawakami Y. (2000) T cells that are autoreactive to &#x3b2;2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. Arthritis Rheum. 43, 65&#x2013;75</Citation><ArticleIdList><ArticleId IdType="pubmed">10643701</ArticleId></ArticleIdList></Reference><Reference><Citation>McRae B. L., Kennedy M. K., Tan L. J., Dal Canto M. C., Picha K. S., Miller S. D. (1992) Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38, 229&#x2013;240</Citation><ArticleIdList><ArticleId IdType="pubmed">1376328</ArticleId></ArticleIdList></Reference><Reference><Citation>Behar S. M., Podrebarac T. A., Roy C. J., Wang C. R., Brenner M. B. (1999) Diverse TCRs recognize murine CD1. J. Immunol. 162, 161&#x2013;167</Citation><ArticleIdList><ArticleId IdType="pubmed">9886382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaburaki J., Kuwana M., Yamamoto M., Kawai S., Matsuura E., Ikeda Y. (1996) Phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies and antiphospholipid syndrome. Intern. Med. 35, 105&#x2013;110</Citation><ArticleIdList><ArticleId IdType="pubmed">8680096</ArticleId></ArticleIdList></Reference><Reference><Citation>Balasubramanian K., Chandra J., Schroit A. J. (1997) Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of &#x3b2;2-glycoprotein I in macrophage recognition. J. Biol. Chem. 272, 31113&#x2013;31117</Citation><ArticleIdList><ArticleId IdType="pubmed">9388264</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt J. E., Simpson R. J., Krilis S. A. (1993) Identification of a region of &#x3b2;2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. Proc. Natl. Acad. Sci. U.S.A. 90, 2141&#x2013;2145</Citation><ArticleIdList><ArticleId IdType="pmc">PMC46041</ArticleId><ArticleId IdType="pubmed">8460120</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed J. H., Giannakopoulos B., Jackson M. W., Krilis S. A., Gordon T. P. (2009) Ro 60 functions as a receptor for &#x3b2;2-glycoprotein I on apoptotic cells. Arthritis Rheum. 60, 860&#x2013;869</Citation><ArticleIdList><ArticleId IdType="pubmed">19248095</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank M., George J., Barak V., Tincani A., Koike T., Shoenfeld Y. (1998) Oral tolerance to low dose &#x3b2;2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome. J. Immunol. 161, 5303&#x2013;5312</Citation><ArticleIdList><ArticleId IdType="pubmed">9820503</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttari B., Profumo E., Capozzi A., Facchiano F., Saso L., Sorice M., Rigan&#xf2; R. (2011) Advanced glycation end products of human &#x3b2;2 glycoprotein I modulate the maturation and function of DCs. Blood 117, 6152&#x2013;6161</Citation><ArticleIdList><ArticleId IdType="pubmed">21498672</ArticleId></ArticleIdList></Reference><Reference><Citation>George J., Harats D., Gilburd B., Afek A., Shaish A., Kopolovic J., Shoenfeld Y. (2000) Adoptive transfer of &#x3b2;2-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 102, 1822&#x2013;1827</Citation><ArticleIdList><ArticleId IdType="pubmed">11023938</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti F., Spinelli F. R., Alessandri C., Pacelli M., Ceccarelli F., Marocchi E., Montali A., Capozzi A., Buttari B., Profumo E., Sorice M., Arca M., Valesini G., Rigan&#xf2; R. (2014) Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on &#x3b2;2GPI-specific T cell response. Arterioscler. Thromb. Vasc. Biol. 34, 661&#x2013;668</Citation><ArticleIdList><ArticleId IdType="pubmed">24436371</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito H., Matsushita S., Tokano Y., Nishimura H., Tanaka Y., Fujisao S., Mitsuya H., Hashimoto H., Nishimura Y. (2000) Analysis of T cell responses to the &#x3b2;2-glycoprotein I-derived peptide library in patients with anti-&#x3b2;2-glycoprotein I antibody-associated autoimmunity. Hum. Immunol. 61, 366&#x2013;377</Citation><ArticleIdList><ArticleId IdType="pubmed">10715514</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvanathan S., McNeil H. P. (1999) Cellular immunity to &#x3b2;2-glycoprotein-1 in patients with the antiphospholipid syndrome. J. Immunol. 162, 6919&#x2013;6925</Citation><ArticleIdList><ArticleId IdType="pubmed">10352314</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeazzi M., Sebastiani G. D., Tincani A., Piette J. C., Allegri F., Morozzi G., Bellisai F., Scorza R., Ferrara G. B., Carcassi C., Font J., Passiu G., Smolen J., Papasteriades C., Houssiau F., Nebro A. F., Ramon Garrido E. D., Jedryka-Goral A., Marcolongo R. (2000) HLA class II alleles associations of antiCL and anti-&#x3b2;2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus 9, 47&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">10715100</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>